Mandal, Ranadip http://orcid.org/0000-0003-2861-9545
Raab, Monika
Rödel, Franz http://orcid.org/0000-0001-6057-1022
Krämer, Andrea
Kostova, Izabela
Peña-Llopis, Samuel http://orcid.org/0000-0003-3847-1353
Medici, Gioele
Häupl, Björn
Oellerich, Thomas
Gasimli, Khayal
Sanhaji, Mourad http://orcid.org/0000-0001-8202-0694
Becker, Sven
Strebhardt, Klaus http://orcid.org/0000-0003-2173-9763
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (MA 9266/2-1)
Deutsche Krebshilfe (70114007))
Deutschen Konsortium für Translationale Krebsforschung
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 12 August 2022
Revised: 11 October 2022
Accepted: 13 October 2022
First Online: 18 November 2022
Change Date: 20 February 2023
Change Type: Update
Change Details: Addition of author Gioele Medici
Change Date: 18 February 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00018-023-04686-y
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose. T.O. received research funding from Gilead and Merck KGaA (unrelated to this work). T.O. is a consultant for Roche and Merck KGaA (both unrelated to this work).
: This study was approved by the Institutional Review Boards of the UCT and the Ethical Committee at the University Hospital Frankfurt (Project Nr.: UCT-13-2021).
: Cervical cancer tissue/tumor samples used in this study were provided by the University Cancer Center Frankfurt (UCT). In addition, written informed consent was obtained from all patients.
: All co-authors have read and approved the final version of the manuscript and its submission.